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Abstract
The composition, presentation, and spatial orientation of extracellular matrix molecules and growth
factors are key regulators of cell behavior. Here, we used self-assembling peptide nanofiber gels as
a modular scaffold to investigate how fibronectin-derived adhesion ligands and different modes of
epidermal growth factor (EGF) presentation synergistically regulate multiple facets of primary rat
hepatocyte behavior in the context of a soft gel. In the presence of soluble EGF, inclusion of dimeric
RGD and the heparin binding domain from fibronectin (HB) increased hepatocyte aggregation,
spreading, and metabolic function compared to unmodified gels or gels modified with a single motif,
but unlike rigid substrates, gels failed to induce DNA synthesis. Tethered EGF dramatically
stimulated cell aggregation and spreading under all adhesive ligand conditions and also preserved
metabolic function. Surprisingly, tethered EGF elicited DNA synthesis on gels with RGD and HB.
Phenotypic differences between soluble and tethered EGF stimulation of cells on peptide gels are
correlated with differences in expression and phosphorylation the EGF receptor and its
heterodimerization partner ErbB2, and activation of the downstream signaling node ERK1/2. These
modular matrices reveal new facets of hepatocellular biology in culture and may be more broadly
useful in culture of other soft tissues.
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1. Introduction
Cells in vivo obtain cues from a complex microenvironment comprising the extracellular matrix
(ECM), autocrine and paracrine growth factors, cytokines, and surrounding cells, the
presentation of which are spatially and temporally specific and which collectively define
unique micromechanical environments [1]. Synthetic matrices with tunable features are
increasingly being used to probe the synergistic roles various cues play in governing cell
behavior, but many such approaches employ chemistries that are not readily accessible to
investigators in cell biology labs. Self-assembling peptide hydrogels, which have been applied
to several tissue engineering applications [2–6], are attractive scaffolds for designing synthetic
ECM for in vitro studies. The basic building blocks are commercially available and gels can
be fabricated in a facile manner to achieve a range of mechanical properties and functionalities.
The gels can be further customized in a modular fashion using standard peptide synthesis routes
to achieve new functionalities. Our objective here was to exploit these features of self-
assembling peptide gels to investigate how different modes of stimulation of epidermal growth
factor receptor (EGFR) regulate hepatocellular behavior synergistically with adhesion
receptors.
We are motivated by observations that hepatocytes undergo robust DNA synthesis and
replication in vivo in a soft tissue environment to regenerate liver mass post-hepatectomy, in
a manner that appears to depend on EGFR stimulation [7]. Primary male rat hepatocytes express
abundant EGFR (>250,000 per cell) [8], which can bind both soluble and matrix-associated
ligands, including EGF, TGF-α, and amphiregulin. In vitro, EGFR stimulation regulates
hepatocyte attachment and survival during the initial stages of culture [8,9] and stimulates
DNA synthesis in low density, highly adhesive cultures [10-13] via signaling pathways
including MAPK/ERK, PLCγ, and PI3K/Akt. The phenotypic responses to EGFR stimulation
may vary with different EGFR ligands due to differences in rates of internalization, trafficking,
and recycling [14]. Interestingly, hepatocellular DNA synthesis in vitro generally requires a
stiff substrate and low cell densities [13,15,16]. Peptide hydrogels offer a facile means to
combine various adhesive and growth factor stimulation modes that mimic cues in the hepatic
sinusoid, including the local mechanical properties, in a manner that may illuminate new facets
of hepatocyte biology. We are particularly motivated to investigate how different mode of
EGFR ligand presentation – soluble or tethered – influence hepatocellular responses in vitro
because the hepatic sinusoid is known to contain tenascin-C [17], a matrix molecule with EGF-
like repeats that activate EGFR in a matricrine manner [18]. Tethering of EGF to the synthetic
ECM gel discourages internalization of ligand-bound EGFR and may alter the balance of the
signaling pathways activated by EGFR [19] in ways that result in different phenotypes than
stimulation with soluble EGF.
As a foundation for creating a synthetic gel microenvironment, we start with the commonly
employed peptide gel backbone AcNRADARADARADARADA-CONH2 (RADA). RADA
peptide gels do not contain any known adhesion motifs or ligands for other cell-surface
receptors; however, functional motifs can be incorporated into the RADA backbone by direct
peptide synthesis [20] and combined in various ratios with unmodified RADA peptide to form
a gel with defined ligand density. Alternatively, incorporation of biotin onto the RADA
backbone allows biotinylated growth factors to be attached to peptide gels through biotin–
streptavidin linkage. The tethering of growth factors in other systems has been shown to
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significantly alter their impact on cell behavior [8,19,21] and can control the spatial and
temporal presentation of growth factors to inhibit receptor downregulation and alter the balance
of signaling pathways [19]. Previously, a variety of adhesion motifs [20,22] and tethered
insulin-like growth factor-1 (IGF-1) [2,6] have been used to functionalize the RADA peptide
gel individually, but to our knowledge this is the first report on the use of peptide gels combining
both adhesive modifications and a tethered growth factor. One point of particular interest in
the hepatocyte cell culture system stimulated with EGFR ligands is that unlike the IGF receptor,
the EGF receptor (EGFR) requires ligand-induced dimerization to initiate signaling. Primary
hepatocytes express low or undetectable levels of the primary EGFR heterodimerization
partner, ErbB2 [12], hence tethering of EGF to peptide gel represents a stringent system for
analysis of the ability of peptide gels to present growth factor in a mode that leads to
physiologically-relevant receptor activation for a receptor requiring dimerization.
In vivo, hepatocytes both make and bind to fibronectin via α5β1 and syndecan-4, hence we
engineered adhesion by including the dimeric RGD motif PRGDSGYRGDS alone or together
with the motif WQPPRARITGY (HB), the consensus heparin binding domain isolated from
fibronectin which is known to bind the fibronectin co-receptor, syndecan-4 [23]. Together,
RGD and HB approximate two co-operative signals required for cell adhesion to fibronectin
[23].
Adhesion and growth factor stimuli regulate cell survival, proliferation, motility, and
differentiation, and the response of cells to synthetic matrices may evolve in culture as autocrine
factors secreted by cells (including matrix and matrix-binding growth factors) accumulate in
the local extracellular environment. We therefore investigated the phenotypic response of
hepatocytes to systematic variation of self assembled peptide gel stimuli using a panel of assays
including immunohistochemistry, quantitative morphometry, and analysis of metabolism and
protein secretion rates during 7 days of culture. Further we examined mechanistic links between
stimuli and observed phenotypes by analyzing activity of intracellular signaling nodes
associated with EGFR and integrin activation.
2. Materials and methods
2.1. Peptides and reagents
Commercially available self-assembling peptides were kindly provided by Dr. Lisa Spirio
(3DM, Tokyo, Japan). Peptides in this category were: RADA-16-I (supplied as 1% w/v or 10
mg/mL; Ac-RADARADARADARADA-CONH2) designated here as ‘RADA’; RGD-
modified RADA [Ac-(RADA)4-GPRGDSGYRGDS-CONH2], designated here as ‘RGD2′,
biotin-modified RADA [Ac-(RADA)4-Biotin-CONH2] designated here as ‘biotinylated
RADA’. RADA modified with heparin binding domain of fibronectin [Ac-(RADA)4-
GGWQPPRARITGY-CONH2], designated here as ‘HB’ was custom synthesized (CPC
Scientific, San Jose, CA). All of the peptide gels made for this study included biotinylated
RADA. The gel compositions and notation used in this report are shown in Table 1.
Human EGF suitable for incorporation into the peptide gel was produced as an engineered
recombinant protein comprising the 53 amino acid human EGF domain fused to a protease-
resistant 20 amino acid hydrophilic spacer arm [24], a single coil domain derived from a high-
affinity coiled-coil pair [25,26], followed by a biotinylation sequence and epitope tag. The
DNA sequence was ordered as a whole gene product with an Escherichia coli codon bias from
GeneArt (Regensburg, Germany). Coding sequences were amplified by PCR mutagenesis with
flanking restriction sites to permit cloning into pMALc2x expression vector (New England
BioLabs). All expression constructs were sequenced prior to the transformation into the
expression strain BL21(DE3)pLysS (Stratagene). Briefly, transformed strains were grown to
OD ~ 0.6 with agitation at 37 °C. Cultures were brought to 25 °C and protein expression was
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induced with a single pulse of 100 nM isopropyl β-D-1-thiogalactopyranoside (IPTG) for 4 h.
Protein was harvested following cell lysis with Bug Buster Master Mix reagent (Novagen)
supplemented with phenylmethylsulphonyl fluoride (PMSF) and protease inhibitor cocktail
(Sigma). Lysates were clarified by centrifugation at 3500g for 1 h at 4 °C. Clear lysate was
subjected to purification on amylose resin in accordance with the pMAL System protocol (New
England BioLabs). Eluted protein was concentrated using an ultracentrifugation cassette (50
kDa molecular weight cut off, Pierce). Purification tags were cleaved by factor Xa digestion
overnight at 30 °C in 20 mM tris, pH 7.4. Purity, quantity, and bioactivity were confirmed by
SDS-PAGE, immunoblot, mass spectrometry, A280 (NanoDrop), and in vitro dose response
vs. natural ligand wild type human EGF (Peprotech) in HeLa cells. Specificity for human EGFR
activation was further assessed by including inhibitor controls using the pan-HER kinase
inhibitor N-(4-((3-Chloro-4-fluorophenyl)amino)pyrido[3,4-d]pyrimidin-6-yl)2-butynamide
(324840, Calbiochem). Biotinylation was carried out using biotin ligase (BirA) in accordance
with vendor instructions (Avidity, Inc.). Extent of biotinylation was confirmed with a 4-
hydroxyazobenzene-2-carboxylic acid (HABA) binding assay (Thermo Pierce). Extents of
biotinylation of over 75% were typical of successful biotinylation reactions. The resulting
EGF–biotin was tethered to RADA containing biotin by linkage through 0.2 mg/mL
NeutrAvidin (31000, Thermo Fisher Scientific, Rockford, IL).
2.2. Gel formation
The peptide gel compositions and notation used in this report are shown in Table 1. Peptides
were sonicated for at least 30 min before use (Aquasonic 50T, VWR Scientific). RADA and
functional peptides (RGD2, HB, and biotinylated RADA) were mixed in the following ratios:
9:1 for RADA + biotinylated RADA; 8:1:1 for RADA + RGD2 + biotinylated RADA and
7:1:1:1 for RADA + RGD2 + HB + biotinylated RADA. Biotinylated RADA was included as
a component in all gels to control for possible alterations in physicochemical properties of gels,
including alterations in bulk mechanical properties [20]. The peptide gels were made in either
12- or 24-well transwell inserts (pore size = 0.4 μm) in 12 or 24 well plates. After sonication,
50 μL (for 12-well) or 70 μL (for 24-well) of peptide mixture was added to the transwell insert
and lowered in a well with either 750 μL or 1 mL of hepatocyte growth media, incubated for
30 min and UV sterilized before use. For making tethered EGF peptide gels (tEGF gels), the
transwell inserts containing peptide gels were washed with PBS after gelation and incubated
with neutravidin (0.2 mg/mL) for 30 min. The neutravidin-linked samples were washed three
times with PBS and incubated with EGF–biotin (0.71 μM) for 30 min. The resulting tEGF
samples were washed three times with PBS and UV sterilized before use. Biotinylated growth
factor bound to RADA peptide gels in this fashion have previously been shown to remain gel-
associated for weeks [2,6].
2.3. Primary hepatocyte isolation
Primary cells were isolated from male Fisher rats weighing between 150 and 250 g as
previously described [27] using Blendzyme III (Roche) in place of collagenase. Following
isolation, cells were resuspended in DAG (Dulbecco’s Modified Eagle’s Medium (DMEM)
with 2 g/L bovine serum albumin (BSA) and 50 mg/L gentamicin) and centrifuged, twice
consecutively, at 50 g for 3 min, resulting in a hepatocyte-rich fraction. Using a ViCell counter
with trypan blue exclusion, final cell viability was determined to range from 90 to 95% with
a cell density between 8 and 13 million cells per milliliter.
2.4. Culture of primary hepatocytes on peptide gels
Following isolation, primary hepatocytes were resuspended in serum-free hepatocyte growth
medium (HGM; low glucose DMEM supplemented with 4 mg/L insulin, 0.1 μM
dexamethasone, 0.03 g/L proline, 0.1 g/L L-ornithine, 0.305 g/L niacinamide, 2 g/L D-(+)-
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galactose, 2 g/L D-(+)-glucose, 1 mM L-glutamine, 50 mg/L gentamicin, 54.4 μg/L ZnCl2,75
μg/L ZnSO4·7H2O, 20 μg/L CuSO4·5H2O, 25 μg/L MnSO4) with or without 10 ng/mL EGF
as indicated. Cells were plated on peptide gels at a density of 100,000 cells/cm2 (for spreading
or signaling assays) or 65,000 cells/ cm2 (for viability or DNA synthesis assays) in either 24-
or 12-well transwell inserts. HGM was replaced after 24 h and again every fourth day of culture.
Cells were incubated at 37 °C, 5% CO2 and 95% humidity for the time periods indicated EGF
was included in cultures as indicated. Transwell inserts adsorbed with collagen I (BioCoat, BD
Biosciences) were used as controls in some experiments.
2.5. Immunofluorescence microscopy
Samples were fixed in 3.7% formaldehyde in phosphate buffered saline (PBS) for 25 min at
room temperature, permeabilized with 1% Triton-X for 10 min at 4 °C and washed with two
changes of PBS for 15 min each. Samples were blocked for 1 h with 10% normal goat serum
(Invitrogen) and 1% BSA in PBS. Samples were incubated with primary antibodies overnight
at 4 °C and washed with 3 changes of PBS for 20 min each. Samples were then incubated with
secondary antibodies, Alexafluor 568-phalloidin, and nuclear stain for 1 h at room temperature,
protected from light, before being washed with 3 changes of PBS for 20 min each. Samples
were then stored in PBS at 4 °C, protected from light. Visualization was done using a Zeiss
Observer A1 microscope equipped with a Photometrics Quant EM S12SC camera and BD
CARV II spinning disc confocal (Biovision Technologies). Images were acquired using
MetaMorph software.
For DNA synthesis assays, after 24, 48 or 72 h in culture, medium was changed to HGM
containing 10 μM of 5-Bromo-2′-Deoxyuridine (BrdU) (B9285, Sigma) to label DNA
synthesizing hepatocytes on peptide gels for 24–48, 48–72 and 72–96 h. After 48, 72 or 96 h,
the experiment was terminated and the incorporation of the BrdU was determined by
immunofluorescence. The samples were fixed, permeabilized and treated with 2 M HCl for 20
min. Acid was removed and samples were washed with PBS containing 0.15% glycine and
0.5% BSA until pH returned to 7. Samples were blocked and stained for primary and secondary
antibodies using routine protocol. Additionally, presence of nuclear antigen Ki67 at these time-
points (48, 72 or 96 h) was also observed by immunofluorescence.
Primary antibodies include anti-rat fibronectin at 1:100 (Millipore), anti-rabbit Ki67 at 1:100
(Abcam), anti-mouse BrdU at 1:200 (Invitrogen). Secondary antibodies at 1:200 and phalloidin
dyes at 1:200 were all AlexaFluor conjugates (Invitrogen). Nuclear stains were used at 1 μg/
mL for 4′,6-diamidino-2-phenylindole (DAPI) (Sigma) and 16.2 mM for Hoechst 33342
(Invitrogen).
2.6. Cell number and viability measurement
Enumeration of live and dead cells was performed using live/dead viability kit (L3224,
Invitrogen) to fluorescently label dead cells with ethidium bromide (EtBr) and all nuclei with
DAPI. In each well, four to six randomly-chosen fields (one from each quadrant of the well)
were observed using a 10 × objective, and all nuclei were counted in each field (300–600 total
nuclei per field). The experiment was performed at least three times. The data were statistically
analyzed with ANOVA followed by Tukey’s test with alpha = 0.05.
2.7. Quantification of urea and albumin production
Culture medium was replaced 48 h prior to collection on the indicated days. Albumin
concentrations were determined using rat albumin ELISA Kit (Bethyl Labs). Urea
concentrations were determined using the QuantiChrom Urea Assay Kit (BioAssay Systems).
Samples, standards and controls were tested in duplicates and experiments were repeated three
to six times. In order to compare with previously published reports, in Figure S2, results are
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reported as μg Product/μg DNA, where μg DNA was estimated using the initial cell number
plated corrected according to viability data and assuming that 1 × 106 cells yields 4 μg DNA
(as reported by Gibco for Trizol Reagent). The data were statistically analyzed with ANOVA
followed by Tukey’s test with alpha = 0.05.
2.8. Quantification of average projected cell aggregate area
Average cell area was quantified as total aggregate area (from phalloidin stained images)
divided by total number of nuclei (from DAPI images) on Metamorph. Four to six individual
images in phalloidin and DAPI channels of each sample were used for each measurement (200–
600 nuclei per measurement). Phalloidin images were used for estimating projected area of
cell aggregates by highlighting the cytoskeleton. Total cell number in the aggregates was
obtained by counting DAPI-stained nuclei. The measurements were performed for four time-
points: 4 h, 24 h, 3 days and 7 days. The experiments were repeated 3–4 times for statistical
significance. The data were statistically analyzed with ANOVA followed with Tukey’s test by
alpha = 0.05.
2.9. Quantification of DNA synthesis
Fluorescent images of DAPI, BrdU and Ki67 staining were used for quantification of
hepatocyte DNA synthesis by Image J. For BrdU images, the fluorescence intensities of the
nuclei were also quantified to account for the variations in the size of the nuclei influencing
signal intensity. The data were statistically analyzed with ANOVA followed with Tukey’s test
by alpha = 0.05.
2.10. Immunoprecipitation
To obtain cell lysates, samples were washed twice with ice cold PBS and lysed in RIPA buffer
(Upstate Biotechnology, Waltham, MA) with protease inhibitors cocktail (Roche, Indianapolis,
IN). Gels and cells collected were incubated on ice and passed through 26 gauge syringes.
Lysates were microfuged at 16,000g for 15 min and supernatant collected. Immunoblotting
was performed by normalizing cell lysates to GAPDH loading controls. Blots were transferred
to nitrocellulose and probed with corresponding primary antibodies (9106 pERK, Cell
Signaling) and secondary IR-Dye conjugate antibodies (IR-Dye700/800, Rockland).
Membranes were scanned using a Licor Odyssey IR scanner (Licor Systems, Inc.). The data
were statistically analyzed with ANOVA and Tukey’s test by alpha = 0.05.
Novagen® bead kits were used for phosphorylated (pTyr) and total EGFR and ErbB2 (EMD
Sciences) and pERK1/2 (BioRad). Ten μg of protein lysates from each sample were incubated
overnight in filter plates (Millipore) with the appropriate antibody-bead conjugates. Unbound
proteins were washed away by vacuum filtration of the plate, trapping the beads in the well.
Beads were rinsed with vendor-supplied buffers and incubated with a biotinylated antibody
specific for a second epitope on the target. Beads were rinsed again and incubated with
streptavidin phycoerythin (Strep-PE), fluorescently tagging the antibody bound to the second
epitope. Total EGFR and ErbB2 fluorescence was normalized to a standard curve generated
with increasing concentrations of the extracellular domain of EGFR and HER2 provided by
the manufacturer (Novagen). The data were statistically analyzed with ANOVA and Tukey’s
test by alpha = 0.05.
3. Results
3.1. Quantitative morphogenesis of multicellular aggregates
The balance of cell–cell and cell–matrix interactions governs the evolution of hepatocyte
aggregate formation and hepatocellular aggregate morphogenesis in culture. Hepatocytes
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plated onto minimally adhesive substrata form attached spherical aggregates within four days
of plating, while cells on moderately- or highly adhesive substrata undergo aggregation while
remaining highly spread [9]. Fibronectin is abundant in the extracellular environment of the
hepatocyte in vivo, and supports attachment and spreading of hepatocytes in vitro [28–30].
Hepatocellular adhesion is also regulated by growth factor receptors such as EGFR. EGFR
stimulation can promote cytoskeletal contraction and cleavage of cell-substrate bonds through
activation of calpain [31], thus, it can also inhibit adhesion, as has been observed for
hepatocytes andother cells seeded on moderately adhesive surfaces in the presence of soluble
EGF [8]. Further, tethered EGFR ligands can elicit dramatically different responses than
soluble ligands in some cell contexts [19], although previous studies in which tethered EGF
was compared to soluble EGF in stimulating hepatocyte spreading and DNA synthesis showed
comparable outcomes for both modes of presentation [8]. We sought here to determine whether
hepatocytes would respond to tethered EGF differentially compared to soluble EGF in a
physiologically-relevant matrix environment (soft hydrogel). We also sought to determine the
effects of RGD2 and HB motifs, targeting adhesion through both integrin (RGD2) and
syndecan-4 (HB), on cell and aggregate morphology.
The morphology of primary rat hepatocytes on peptide hydro-gels was observed at 4 and 24
h, 3 and 7 days. Hepatocytes attached and spread to form monolayer clusters or aggregates on
all peptide gel formulations; however, the overall area of aggregates, as well as the average
cell area within an aggregate, significantly increased upon inclusion of adhesion ligands and
growth factor modifications. On functionalized peptide gels, even as early as 4 h after plating,
hepatocytes have discernibly higher cortical actin and elongation of the cell body, as observed
in the Alexafluor 568-phalloidin stained images (Supplemental data, Figure S1). The most
striking difference in hepatocyte morphology (aggregate size and area per cell) as a function
of the peptide gel composition was observed on day 3 as shown in Fig. 1A. With inclusion of
RGD2 motifs, the cell aggregate areas increase; this effect is further enhanced by inclusion of
HB with RGD2. Surprisingly, in gels that lack the HB domain, soluble and tethered EGF exert
dramatically different effects on cell and aggregate morphology. In contrast to soluble EGF,
which is associated with small aggregates, tethered EGF drives formation of large aggregates
with relatively well-spread cells (Fig. 1A). In order to determine the impact on individual cell
spreading, the average aggregate area and average area of each cell were calculated from the
total aggregate area and the number of nuclei within each aggregate (Fig. 1B and C).
On RADA gels on day 3, hepatocytes exposed to soluble EGF exhibited an average cell area
of 850 μm2 – comparable to the projected area of a spherical hepatocyte – and average aggregate
size was relatively small (6760 μm2, Fig. 1C). However, hepatocytes exposed to tethered EGF
on the RADA gel resulted in aggregates almost 20-fold larger (121,000 μm2) with 1.3-fold
greater spread areas per cell (1080 μm2). Inclusion of the dimeric RGD2 domain (RADA +
RGD2) in gels without tethered EGF increased the aggregate area by 6-fold (to 43,100 μm2)
and the per cell area by 1.2-fold (to 1040 μm2) and addition of both the dimeric RGD2 domain
and the heparin binding domain (RADA + RGD2 + HB)increased average aggregate area yet
9-fold further (to 388,000 μm2) and likewise the cell spread area by another ~40% (to 1440
μm2) in comparison to RADA with soluble EGF. Addition of tethered EGF to these adhesion
ligand-modified peptide gels lead to a further increase in the hepatocyte cell and aggregate area
at day 3. With just the RGD2 ligand, tethered EGF increased aggregate area 12-fold (to 525,000
μm2) and cell area 1.6-fold (to 1730 μm2). Inclusion of tethered EGF in gels with both the
RGD2 and HB domains increased aggregate area 1.6-fold and average cell area 1.4-fold (to
1950 μm2) over values for cells on the same gels in the presence of soluble (but not tethered)
EGF.
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3.2. Synergistic effects of adhesion peptides and EGF on hepatocyte viability
Hepatocyte survival in culture is influenced by cell–matrix adhesion and growth factor
stimulation [9,10,27,32]. EGF can act as both a pro-survival signal and as a pro-death signal
depending on the context [27]. In the absence of exogenous EGF (either tethered or soluble),
hepatocytes on peptide gels show very low viability (20–50%) at day 3 that decreases over
time in culture (data not shown). To determine whether the adhesive and growth factor
modifications differed in their ability to support hepatocyte viability, we stained the nuclei of
cells cultured in the presence of various combinations of adhesion ligands and growth factors
with ethidium bromide (to label dead cells) and DAPI (to label all cells) and quantified the
number of each in multiple representative fields for each condition (Fig. 2). Although plating
efficiency was high for all conditions (Fig. 2B), cell numbers slightly declined for gels with
the least adhesive phenotype (RADA) but increased for cells on the most adhesive phenotype
(RADA + RGD2 + HB + tEGF) The decline in cell number was associated with lower viability
in the early cell number stages of culture (Fig. 2A).
Peptide gels with RGD2 + HB + tEGF supported survival of hepatocytes at a greater level than
peptide gels with no modifications at all time-points. After 24 h and 3 days, hepatocytes on
RADA + RGD2, RADA + RGD2 + HB, RADA + RGD2 + tEGF, RADA + RGD2 + HB +
tEGF had significantly higher viability than on RADA alone. However, by day 7, only
hepatocytes on RADA + RGD2 + HB + tEGF had a significantly higher viability than on
RADA alone. By seven days, the viability of hepatocytes was similar on most peptide gels,
which may be the result of cell-secreted matrix accumulation. The apparent increase in viability
of hepatocytes on peptide gels is due to gradual loss of dead cells by detachment during media
changes, phagocytosis, or disintegration following apoptosis. These results are consistent with
previous work demonstrating the importance of cell–matrix adhesion for growth factor
signaling and the combination of both cues to cell survival [33]. Tethered EGF has a much
stronger positive impact on hepatocyte survival on peptide gels than soluble EGF, a
phenomenon that may arise from either sustained signaling by surface-restricted EGFR, or
alteration of the balance of EGFR-mediated pathways toward pro-survival pathways including
PI3 kinase/AKT.
3.3. Accumulation and assembly of cell-secreted fibronectin
Fibronectin is abundant in the liver sinusoids where hepatocytes produce plasma fibronectin
for the blood supply of the entire organism [34]. Hepatocyte-produced fibronectin is in close
contact with the cell-surface, and hepatocytes express the fibronectin binding integrin α5β1
and fibronectin co-receptor syndecan-4. To determine if hepatocytes on peptide gels produced
and accumulated fibronectin, we used immunofluorescence microscopy to observe
extracellular (fibrillar and non-fibrillar) and intracellular fibronectin produced by hepatocytes
(Fig. 3). Overall, hepatocytes on unmodified gels showed little accumulation of fibronectin,
while inclusion of RGD2, HB, and tethered growth factor modifications increased amounts of
intracellular, soluble and fibrillar fibronectin at days 3 and 7.
On RADA peptide gels with soluble EGF, there was no fibronectin fibril assembly but weak
staining of soluble (non-fibrillar) fibronectin observed on the surface of the peptide gels.
Addition of RGD2 to RADA with soluble EGF increased the amount of nonfibrillar fibronectin.
On inclusion of RGD2 and HB into peptide gels with soluble EGF, fibronectin fibrils
(arrowheads) were observed on the gel surface. Moreover, with this gel configuration (RADA
+ RGD2 + HB), intracellular fibronectin (arrows) was also observed. No detectable
fluorescence was seen when RADA + RGD2 gels without cells were incubated with anti-
fibronectin antibody (data not shown).
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Addition of tethered EGF to RADA increased the soluble staining for fibronectin on the peptide
gel surface. On peptide gels containing either RGD2 or RGD2 + HB, the presence of tethered
EGF led to increases in the intracellular and soluble fibronectin as well asassembly of
fibronectin fibrils. In contrast to fibronectin assembly at day 3, as summarized above,
immunofluorescence for fibronectin on peptide gels fixed at either 4 or 24 h showed little
presence of fibronectin (data not shown). However at day 7, there was much more intracellular,
soluble and fibrillar fibronectin on RADA + RGD2 + HB + tEGF peptide gels (data not shown)
mirroring the same trend with respect to the peptide gel composition as on day3.
3.4. Hepatocyte DNA synthesis
While the liver can regenerate in vivo, in vitro it is difficult to get primary hepatocytes to enter
into the cell cycle. Previous work has shown insulin and EGF (or TGF-α) stimulation in
vitro prompts entry of primary adult hepatocytes into the cell cycle and synthesis of DNA, after
a lag of 40 h, peaking between 48 and 72 h on collagen I coated tissue culture plastics [35].
However, matrices known to be similar in stiffness to liver tissue have been shown to inhibit
that response [15]. In order to test the capacity of different compositions of peptide gels to
support hepatocyte entry into the cell cycle Ki-67 staining was used to label cells in the active
phases of the cell cycle (G1, S, G2, M) and DNA synthesis was quantified by BrdU
incorporation. We quantified DNA synthesis via immunofluorescence staining as the
percentage of total nuclei incorporating BrdU (within 24–48, 48–72 or 72–96 h) or as the
percentage of total nuclei staining positive for Ki67 (at 48, 72 or 96 h) (Fig. 4). The presence
of tethered EGF, RGD2, and HB were found to be critical for primary rat hepatocytes to
synthesize DNA on peptide gels.
Remarkably, of the time-points and compositions tested, EGF-mediated DNA synthesis was
only observed on peptide gels with RGD2, HB and tEGF modifications during the 48–72 h
period of culture. We observed no DNA synthesis on any other peptide gel (RADA, RADA +
RGD2, RADA + RGD2 + HB) even in the presence of soluble EGF. However, on adsorbed
collagen type I in the presence of soluble EGF, we observed DNA synthesis via incorporation
of BrdU and presence of Ki67 nuclear antigen at all time-points (40% BrdU incorporation in
24–48 h, 49% in 48–72 h, 44% in 72–96 h, and 28% Ki67 positive cells at 48 h, 35% at 72 h,
30% at 96 h). To compare, hepatocytes on RADA + RGD2 + HB + tEGF gels between 48 and
72 h showed 41% BrdU incorporation and 32% Ki67 positive cells. There is an expected
difference between BrdU-positive cells and Ki-67-positive cells because BrdU incorporation
was done over a 24-h period (ie. 24–48, 48–72 and 72–96 h) while the presence of Ki67 was
detected only at the time of fixation.
These results are particularly interesting given that soft substrates of any composition are
typically less supportive of hepatocyte entry into the cell cycle; in the presence of soluble EGF,
DNA synthesis on a soft collagen I gel is only ~30% of that on adsorbed collagen I [15].
However, DNA synthesis rates on RADA + RGD2 + HB + tEGF peptide gels are similar to
those on adsorbed collagen I with soluble EGF between 48 and 72 h. This suggests that the
RADA + RGD2+HB + tEGF peptide gel captures certain aspects of the hepatocyte environment
in vivo, where DNA synthesis proceeds in a soft mechanical environment.
3.5. Activation of fibronectin- and EGFR-mediated intracellular signaling pathways
Since integrins and growth factors are each known to trigger activation of the extracellular
signal-regulated kinase (ERK) class of mitogen activated protein (MAP) kinases, we examined
ERK activation as a pathway potentially involved in mediating the phenotypic differences seen
on the various peptide gels. We monitored the presence of total and phosphorylated ERK (1
and 2), EGFR and ErbB2, the primary heterodimerization partner of EGFR, in primary cultures
of rat hepatocytes on peptide gels. Tethered EGF induced higher levels of activation of EGFR
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and ERK1/2 on various peptide gel compositions at later time-points compared to soluble EGF.
Early (30 min) and sustained (24, 48 and 72 h) levels of ERK phosphorylation on peptide gels
with either tethered or soluble EGF were quantified and data for later time-points are shown
in Fig. 5.
Comparison of peptide gels with or without RGD2 at 30 min and 24 h yields similar ERK
phosphorylation with soluble or tethered EGF (data not shown). However, at 48 and 72 h, on
RADA, RADA + RGD2 and RADA + RGD2 + HB peptide gels, tethered EGF induced
statistically higher ERK activation than soluble EGF. While there were striking differences
with the various combinations of adhesive ligands in terms of cell spreading, viability, and
metabolic function, there were no discernable differences between ERK phosphorylation at
any of the time-points among any of the adhesion ligands; the only significant change in
ERK1/2 phosphorylation arose from differences in the mode of EGFR stimulation (soluble
vstethered EGF). This result was not unexpected, despite the robust phenotypic differences
seen with the inclusion of adhesive modifications, as it has previously been reported that ERK
signaling goes down after an initial period of attachment and spreading [36].It is also possible
that robust signaling downstream of EGFR is obscuring signaling downstream of integrins.
In many cell types, activation of ERK1/2 by EGFR can be modulated by heterodimerization
with the EGFR family member ErbB2. Although ErbB2 is normally expressed at low or
undetectable levels in hepatocytes in vivo, its expression and activation status is induced in
culture and is modulated by growth factors and hormones [12]. Hence, we examined the
expression and phosphorylation of both EGFR and ErbB2 in primary rat hepatocytes cultured
on different gel compositions. While inclusion of adhesion ligands (RGD2 and RGD2 + HB)
increased EGFR phosphorylation in the presence of soluble EGF over levels observed on
unmodified RADA at 72 h (Fig. 6B), the inclusion of adhesion ligands had little impact on the
phosphorylation of the EGFR at the time-points examined. However, tethering of EGF had a
dramatic impact on the total receptor levels and their phosphorylation at 48 and 72 h (Figs. 6A,
B and 7A, B). EGFR phosphorylation (normalized to total EGFR and GAPDH) on all tethered
EGF peptide gels was statistically higher than on their soluble EGF counterparts. ErbB2
phosphorylation showed the opposite pattern: ErbB2 phosphorylation (normalized to total
ErbB2 and GAPDH) at 48 and 72 h was statistically lower on peptide gels with tethered EGF
compared to their soluble EGF counterparts (Fig. 6C and D). Thus, the data indicate that EGFR
is more extensively phosphorylated in the presence of tethered EGF, while ErbB2 is more
extensively phosphorylated in the presence of soluble EGF.
Examination of total receptor levels, over time and in relation to freshly isolated hepatocytes,
shows that in the presence of soluble EGF, EGFR levels decrease (Fig. 7A and B) while levels
of ErbB2 increase (Fig. 7C and D). However, on peptide gels with tethered EGF, EGFR and
ErbB2 levels both remain stable over time and when compared to fresh isolates, with EGFR
levels being higher than ErbB2 levels (Fig. 7A–D). Previous reports have indicated that
tethering of EGF can inhibit degradation of EGFR [19], which we observe here. However,
others have shown that culturing hepatocytes in vitro leads to an up-regulation of ErbB2,
typically not found on hepatocytes in vivo [12,37]. The ability of tethered EGF peptide gels to
minimize or prevent up-regulation of ErbB2 may be further indication that this system captures
cues that are critical to maintenance of hepatocyte differentiation. Further, these differences in
EGFR and ErbB2 phosphorylation and dynamics between soluble and tethered EGF have not
been previously reported and present an interesting avenue of future inquiry.
The similarity in the phosphorylation patterns of ERK1/2 and EGFR supports the conclusion
that the absence of an adhesion-mediated phosphorylation difference is the result of strong
signaling downstream of the growth factor receptor obscuring differences downstream of
integrins. The data on ERK and EGFR activation are consistent with previous observations
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with different cell types plated on surfaces with tethered EGF [19]. Thus, tethering EGF on
peptide gels likely permits sustained EGF signaling since EGFR binding to tethered EGF
inhibits endocytosis and degradation. This sustained EGF signaling may also explain the
differences in viability between peptide gels with either soluble or tethered EGF ligands.
3.6. Coregulation of hepatocellular metabolic function by fibronectin peptides and tEGF
Hepatocytes perform numerous metabolic, endocrine and secretory functions in the liver,
including synthesis of lipids, proteins and carbohydrates. However, primary hepatocytes
typically show a dramatic decrease in these metabolic functions in vitro in standard culture
conditions [38]. Here, we examined two of the critical metabolic functions of adult hepatocytes
that are rapidly lost under standard cell culture conditions: urea production and albumin
secretion. Addition of adhesive fibronectin moieties in conjunction with tethered growth
factors dramatically improved the ability of hepatocytes to maintain these metabolic functions.
Peptide gels with RADA + RGD2 + HB + tEGF supported the highest levels of urea and
albumin production by hepatocytes at all time-points, providing a statistically significant
increase over standard adsorbed collagen I culture conditions. Fig. 8 shows the urea (8A) and
albumin (8B) produced by hepatocytes as a function of time on either peptide gels or adsorbed
collagen type I.
Albumin secretion by hepatocytes at 24 h, 3 and 7 days on all peptide gels, except RADA at
24 h, was significantly higher than cells on adsorbed collagen type I. Further, addition of RGD2,
HB and/or tEGF to the peptide gels significantly improved albumin secretion relative to the
non-instructive, unmodified RADA gel. At all time-points, RADA + RGD2 + HB + tEGF
showed the highest level of albumin secretion of all the gels. Urea production was significantly
higher on all peptide gel formulations, regardless of composition, at all time-points relative to
collagen I. Similar toalbumin, inclusion of RGD2, HB, and/or tEGF resulted in a statistically
significant improvement in urea production relative to the unmodified RADA gel. Further,
normalization of albumin and urea production rates based on total cell numbers for each time
point, shows our values are within the range of those typically reported in a variety of other
engineered culture systems [38,39].
On peptide gels with the following compositions: RADA + RGD2 + HB, RADA + RGD2 +
tEGF, RGD2 + HB + tEGF, albumin and urea secretion by hepatocytes was significantly higher
than on adsorbed type I collagen. These phenotypic differences are expected given the ability
of the modified peptide gels to engage fibronectin binding-integrins, -syndecans, and/or growth
factor receptors, which would not be activated on collagen I. The morphology of the cells may
also be linked to these differences given that the hepatocyte area on these gels was significantly
lower than adsorbed type I collagen and approximated values reported for hepatocytes in vivo
(~2000 μm2 for RADA + RGD2 + HB + tEGF on day 3, versus ~7000 μm2 for adsorbed
collagen I, versus ~2200 μm2 in vivo) and previous studies have shown that maximally spread
hepatocytes have a lower metabolism compared to cells with intermediate levels of spreading
[15,16,40].
4. Discussion
Biologically inspired self-assembling peptide gels have shown utility in the culture and
manipulation of a variety of cell types. By itself, the standard peptide backbone, RADA, does
not interact specifically with cells; however, it can be easily functionalized by incorporating
short chain peptides with glycine spacers to the C-terminus of the RADA chain [4,20]. Use of
peptide gels with such strategies has shown promise in bone, cartilage, neural, and cardiac
regeneration [2–5,20,22,41]. Previously self-assembling peptide gels have shown limited
success for the culture of primary hepatocytes [22]. However, this is the first report of the
combinatorial use of functional motifs capable of engaging integrins, syndecans and growth
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factor receptors. Here, we demonstrate that self-assembling peptide gels, by virtue of the
modular nature of their modifications, can be functionalized to present adhesive ligands and
growth factor signals relevant to a soft tissue microenvironment.
Taking cues from hepatocyte environments in vivo, we chose adhesive ligands and a growth
factor relevant for the hepatic microenvironment [34]. Hepatocytes express over 200,000 EGF
receptors and EGF signaling mediates their morphology, survival, DNA synthesis, and
differentiated function. The hepatic sinusoid contains tenascin-C [17], a matrix molecule with
EGF-like repeats that are known to activate EGFR in a matricrine fashion [18]. Hence, we
created environments that would mimic the matricrine presentation of EGF, anticipating that
such presentation would inhibit internalization and downregulation of EGFR, and alter the
balance and duration of downstream EGFR signaling pathways compared to soluble EGF.
Hepatocytes express three integrin adhesion receptors: α1β1, α5β1 and α9β1 for binding
collagen type I, fibronectin and tenascin-C, respectively [42]. We complemented the
presentation of EGF in tethered format by including two key cell adhesion peptide domains,
the RGD cell-binding domain and the heparin binding from fibronectin to engage α5β1 integrin
receptor and its co-receptor, syndecan-4, respectively. The local concentrations of peptide in
the gel are estimated to be sufficient for driving receptor dimerization or clustering. The average
spacing between two adhesion ligands included at a 1:9 ratio in the gel is estimated to be 8–
15 nm, based on the reported dimensions of the nanofibers formed from the gels [43]. These
spacings should be sufficient to cluster adhesion receptors [44]. EGF is tethered via a biotin
linkage to neutravidin, thus estimates of spacing between EGF are 3–6 nm in the peptide gel,
which is sufficient to allow dimerization of EGF receptors [45]. This process used to design
modifications of the peptide gel for hepatocellular culture could be undertaken for other soft
tissue microenvironments (Fig. 9).
In the liver sinusoid, sheets of hepatocytes are held together by cell–cell contacts while the cell
membranes are in direct contact with fibronectin-containing matrix. However, in vitro, it has
been demonstrated that on insufficiently adhesive substrates, the strength of cell–cell contacts
predominate, resulting in spheroids of primary hepatocytes [9]. It has also been shown that
supra-physiological cell spreading, such as seen on adsorbed collagen, decreases the metabolic
activity of hepatocytes, suggesting that there is an optimal cell morphology associated with
maintenance of hepatocyte differentiation [16]. Cell and aggregate morphology have typically
been manipulated with combinations of matrix and soluble factors; here, we compared the use
of soluble versus surface-tethered EGF as a means to manipulate cell and aggregate
morphology and resulting hepatocellular phenotypes.
Not surprisingly, inclusion of adhesion ligands in the peptide gels increased the size of
hepatocellular aggregates as well as the average cell area within aggregates (Fig. 1).
Hepatocytes seeded in culture as single cells attach and undergo an aggregation process
characterized by extension of filipodia, contact with neighbors, and movement toward
neighbors to increase cell–cell contact resulting in well-spread monolayers on sufficiently
adhesive substrates and rounded spheroids on insufficiently adhesive substrates. In this system,
matrix adhesion is mediated by α5β1 and its co-receptor, syndecan-4, the cooperation of which
has been shown to be required for optimal cell attachment, spreading, and motility in a variety
of cell types [23,46,47]. While it has been reported that soluble syndecan-4 ligands, such as
fibronectin, can induce appropriate integrin-syndecan-4 interactions [23,46], we do not believe
that soluble factors are responsible for the early stages of attachment and spreading or the
morphological differences reported here at day 3. Although unmodified RADA gels can
nonspecifically adsorb adhesion proteins present in serum or secreted by cells ([41] and Fig.
3), no serum was present in these cultures and the time scale for cell-secreted fibronectin
accumulation (days) appears to preclude its influence on early (up to day 3) events, such as
attachment, spreading, and aggregation. Thus, the data indicate that inclusion of minimal
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adhesion ligands, RGD2 and HB, greatly increases the average aggregate size and the average
cell area of hepatocytes on modified gels with simultaneous ligation of α5β1and syndecan-4
(RADA + RGD2 + HB) showing a greater increase than α5β1 alone (RADA + RGD2).
However, hepatocyte morphology is not governed solely by adhesion ligands. Under conditions
of moderate-to-high matrix adhesivity, soluble EGF stimulates cell motility [48,49], despite it
being anti-adhesive to hepatocytes on poorly adhesive substrata [8]. Hence, it has previously
been shown that soluble EGF works in concert with matrix adhesion to facilitate motility and
aggregate formation in the early stages of culture. In this report, a dramatic effect on cell
morphology was observed for tethered EGF, which increases attachment and spreading of other
cell types [21,50], possibly through an N-wasp mediated mechanism leading to local
polymerization of actin [51]. Thus, it was expected and shown here that integration of signals
from α5β1, syndecan-4, and EGFR (RADA + RGD2 + HB + tEGF) would result in the most
extensive attachment and spreading of the peptide gel combinations.
Morphological differences associated with the different adhesion environments also correlated
with differences in hepatocyte viability and metabolism. In general, the RADA gel modified
with the full compliment of ligands, RGD2, HB, and tEGF, which also supported the largest
aggregate and cell areas, was best able to support the desired phenotypes. Hepatocyte cell areas
on peptide gels reported here for the most highly modified gel (1950 μmm2 forRADA + RGD
+ HB + tEGF at day 3) are similar to the dimensions of hepatocytes in vivo (~2200 μm2) [40]
and much less spread than cells on type I collagen (~7000 μm2) [15,16]. These morphological
differences correspond with differences in metabolic function between unmodified and
modified peptide gels and adsorbed collagen I that are consistent with other literature reports
of poor retention of function in highly spread hepatocytes [16]. They also correspond with
viability at early time-points (one and three days), where gels modified with RGD2 and RGD2
+ HB show a statistically significant increase in viability. However, after a week in culture,
cell viabilities were similar across all modifications. We speculate that accumulation of
hepatocyte-secreted soluble fibronectin (Fig. 3) provides a pro-survival adhesion stimulus to
cells at later time-points in culture.
The profound differences in cell and aggregate morphology, along with correlated differences
in viability and metabolic function, suggested that increased adhesion, and presentation of EGF
in tethered rather than soluble format, might alter downstream signaling. ERK is a common
signaling pathway activated upon integrin clustering and/or binding of EGF to EGFR [36,52,
53], and integrin-mediated adhesion increases ERK phosphorylation and DNA synthesis in the
presence of growth factors in some cell types [36]. Interestingly, in the presence of soluble
EGF, activation of ERK1/2 appears only slightly sensitive to addition of the RGD2 or HB
domains to the peptide gels (Fig. 5A and B), with overall values much higher than initial isolates
(taken at a time point immediately following enzymatic digestion and centrifugation to enrich
for hepatocytes) and remaining approximately unchanged from the 48–72 h point. The
phosphorylated ERK1/2 values are lower for cells cultured on gels than for those cultured on
adsorbed collagen I, a rigid substrate. Strikingly, ERK1/2 shows greatly increased activation
levels in cells cultured in the presence of tethered EGF on all peptide gel formulations at both
time points, compared to the same adhesive conditions with soluble EGF. These results are
intriguing in light of recent reports that enhanced ERK activation in hepatocytes can drive a
pro-death phenotype [54–56] while we see it correlating with increased viability. Clearly,
ERK1/2 act in a context-dependent fashion and may yield pro-survival signaling in the context
of the peptide gel adhesion environment compared to the previous studies where cells were
cultured on rigid substrates.
An obvious explanation for the enhanced activation of ERK1/2 in the presence of tethered EGF
compared to soluble EGF for cells on peptide gels is retention of EGFR expression via
inhibition of internalization and degradation of the EGFR. Examination of EGFR levels under
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the different culture conditions (Fig. 7A and B) indicates that EGFR expression is
downregulated under all soluble EGF culture conditions, but is maintained at expression levels
comparable to freshly isolated cells for all tethered EGF conditions. Because signaling by
ligand-bound EGFR can be rapidly shut off by intracellular phosphatase activity, in addition
to degradation, we examined levels of pEGFR under all conditions at time points of 0, 48 and
72 h. The fraction of activated EGFR (pEGFR/total EGFR) was slightly higher for the tethered
compared to the soluble case at 48 h and dramatically higher at 72 h; taken together with the
significantly higher total EGFR levels for the tethered EGF case, pEGFR was very significantly
increased in all conditions involving tethered EGF. This increased activity of EGFR is
consistent with the increased levels of pERK1/2 observed for these conditions.
The increased ERK1/2 activation for the tethered EGF case could have also arisen from up-
regulation of ErbB2, a preferred heterodimerization partner for EGFR and a potent stimulator
of several signaling pathways downstream of EGFR. Increased expression of ErbB2 is often
a driver of malignant phenotypes in epithelial cells [57]. Primary adult male rat hepatocytes
have previously been reported to express undetectably low levels of ErbB2, but upregulate
expression dramatically by 48 h in culture on adsorbed collagen I in the presence of insulin
and EGF [12]. Dexamethasone, a common additive to serum-free hepatocyte culture media,
mitigates the ErbB2 up-regulation and maintains EGFR expression in a highly dose-dependent
fashion [11]. Using a different strain of rats (Fischer vs Sprague Dawley) and a different method
of quantifying ErbB2 (immunobead assay vs densitometry of Western blots), we found that
freshly isolated adult male hepatocytes express low levels of ErbB2 (Fig. 7C). Consistent with
the previously published observations of Scheving et al. [11,12,37], total ErbB2 is dramatically
upregulated in the first 48–72 h for hepatocytes cultured on rigid collagen I in the presence of
insulin and EGF. Our cultures contain an intermediate concentration of dexamethasone (100
nM) hence the level of up-regulation is consistent with the previous report [11]. The increased
ErbB2 expression was accompanied by a high degree of ErbB2 phosphorylation (Fig. 6).
Surprisingly, given the differences in morphology and function described earlier, the up-
regulation and phosphorylation of ErbB2 in hepatocytes cultured on peptide gels in the
presence of soluble EGF almost precisely mirrored that of cells cultured on rigid collagen I in
the presence of soluble EGF (Figs. 6 and 7). More surprisingly, tethered EGF suppressed up-
regulation and reduced phosphorylation of ErbB2 entirely under all conditions (Figs. 6 and 7).
We infer from these results that presentation of EGF tethered via neutravidin to the peptide
gels is sufficient to allow homodimerization of the EGFR, although we do not rule out release
of autocrine EGFR ligands as a means of homodimerization as hepatocytes make abundant
TGF-α [27]. It has also been reported that EGFR can be activated by α5β1 through a Src-
dependent mechanism [58], and it is thus possible that juxtapositioning of the ligand-bound
EGFR to ligand-bound integrins contributes to activation of EGFR [33]. Further studies are
underway to explore these possibilities.
Finally, the most unexpected result in this study was the observed pattern of DNA synthesis
on peptide gels. Under specific conditions, primary adult rat hepatocytes in culture can be
stimulated to enter the cell cycle and synthesize DNA – those conditions typically include
strong cell adhesion, extensive spreading, low cell density (<50,000 cells/cm2), stiff
substratum, presence of insulin, and EGF signaling with prolonged downstream activation of
ERK1/2 [12,13,15]. However, hepatocytes in vivo are capable of entering and continuing
through the cell cycle during liver regeneration, even though the liver is a relatively soft
microenvironment where cells are densely packed, and are not extensively spread. We
quantified DNA synthesis at time-points commonly associated with hepatocyte DNA synthesis
in primary culture (between 48 and 72 h) using direct counting of BrdU-labeled nuclei. For
cells cultured on rigid collagen I, the amount of DNA synthesis (Fig. 4) is within an expected
range for this condition given the relatively high cell densities used (65,000 cells/cm2).
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However, cells on peptide gels did not exhibit any measurable DNA synthesis in the presence
of soluble EGF for any of the adhesive conditions (Fig. 4). In the presence of tethered EGF,
only peptide gels modified with RGD2, HB, and tethered EGF, from 48 to 72 h, promoted
DNA synthesis by ~40% of hepatocytes (compared to ~50% for hepatocytes on collagen I
during the same time period). This observation of hepatocyte DNA synthesis on a substrate
approximating physiological stiffness is notable. While a previous study has illustrated that
primary hepatocytes can be induced to synthesize DNA on soft collagen substrates by inhibiting
PKA activity [15], mimicking PKA levels on stiff collagen substrates, we show here that the
soft modified peptide gel can elicit the same response in the absence of specific pathway
inhibitor. The mechanism responsible for DNA synthesis on peptide gels is currently unknown,
but it is unlikely it is mediated by ERK1/2 as the activation levels of ERK1/2 are comparable
for all tethered EGF substrates at all time-points studied. Additional pathways downstream of
EGFR (including JNK, PKC, STAT, PLCγ) and integrins (including JNK, ROCK, AKT, PAK)
are candidates for the regulation of behavior and the subject of ongoing studies.
This pattern of DNA synthesis is also remarkable because previously, DNA synthesis by cells
on collagen I in the presence of soluble EGF has been linked to increased expression and
phosphorylation of ErbB2. Comparing cells on peptide gels (a soft substrate with mechanical
properties similar to normal liver) versus collagen I (a rigid substrate) in the presence of soluble
EGF shows an increase in ErbB2 expression under both culture conditions relative to freshly
isolated hepatocytes. However, cells on peptide gels exhibit lower levels of ERK1/2 and ErbB2
activation with soluble EGF compared to cells cultured on collagen. While this would appear
to explain the lack of DNA synthesis on the peptide gels with soluble EGF, results with tethered
EGF indicate a more complicated scenario. The only condition on which DNA synthesis is
observed on the gels, RADA + RGD2+HB + tEGF, corresponds to ERK1/2 activation in the
absence of ErbB2 up-regulation or phosphorylation (levels are comparable to fresh isolates).
It would appear that, unlike cultures with soluble EGF on collagen I or peptide gels, DNA
synthesis is stimulated via tethered EGF activating EGFR and ERK1/2 without altering levels
of EGFR or ErbB2. While there were no differences observed in the levels of phosphorylation
of EGFR, ErbB2 or ERK1/2 between gels with different adhesion ligands, DNA synthesis was
only observed in the presence of RGD2 and HB, indicating that integrin and syndecan signaling
are critical. In summary, RADA + RGD2 + HB + tEGF stimulated hepatocyte DNA synthesis
by increasing activation of EGFR and ERK1/2, yet maintaining EGFR, ErbB2, and the
phosphorylated ErbB2 at levels found in fresh isolates.
These discoveries set the stage for additional investigations of how the mode of growth factor
presentation, in concert with adhesion receptor engagement, regulates hepatocellular survival
and apoptosis under conditions of cell stress, such as stimulation with inflammatory cytokines
or infection with a virus. When exposed to certain inflammatory cytokine combinations,
hepatocytes initiate a set of self-antagonizing autocrine loops involving EGFR receptor ligands
along with IL1-α, IL1-β, and IL1-ra [27]. These autocrine loops work in concert with
exogenous EGFR ligands (and other factors) in non-linear ways to dictate cell phenotypic
responses (life or death). We speculate that the new observations here regarding hepatocellular
responses to stimulation by tethered EGF may illuminate additional critical facets of
hepatocellular biology in the future.
5. Conclusion
The results described in this report strengthen the accumulating evidence that matrix
mechanical properties and composition co-regulate cell functions ranging from survival to
differentiation by demonstrating the phenotypic and signaling responses to a panel of stimuli
with systematic variation in properties. The results also add an extra dimension to this
conceptual view, in that the mode of growth factor presentation (soluble vs. tethered) is a critical
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determinant of phenotypic outcomes that depend on synergistic stimulation of adhesion and
growth factor receptors, perhaps through regulation of growth factor receptor trafficking. The
system employed in this work may find use in investigations of cell types from other soft
tissues, where interactions between fibronectin receptors and EGFR are implicated in cellular
responses.
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Fig. 1.
Self-assembling peptide gels functionalized with the cell-binding domain and heparin binding
domain of fibronectin and tethered EGF influence hepatocyte morphology and adhesion. A)
Representative fluorescent actin cytoskeleton images (5× objective) for hepatocytes on RADA,
RADA + RGD2, RADA + RGD2 + HB peptide gels with soluble EGF or tEGF, 3 days after
initial seeding (Scale bar = 400 μm). B) Quantification of average cell aggregate area at day 3
on peptide gels, and C) Quantification of average cell area at day 3 on peptide gels expressed
as ratio of total aggregate area and total nuclei counted. Fluorescent actin and DAPI images of
each peptide gel sample (seeded at 100,000 cells/cm2) were taken in 4–5 fields at each time
point. * indicates statistically significant difference from RADA with soluble EGF, p < 0.05,
n > 3.
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Fig. 2.
Adhesion ligands and tethered growth factor modulate hepatocyte viability on self-assembling
peptides for seven days in culture. A) Quantification of cell viability expressed as percentage
live cells as a function of gel composition, B) Total cell numbers as a function of time in culture.
Hepatocytes on RADA, RADA + RGD2 RADA + RGD2 + HB peptide gels with soluble EGF
or tEGF (seeded at 65,000 cells/cm2) were stained with EtBr and DAPI at each time point.
Images representing four random fields were taken on each peptide gel sample. Cell viability
was defined as the fraction of non-EtBr stained cells in the field. Except adsorbed collagen I
(ads. col I), all peptide gels contained RADA. * indicates statistically significant difference
from RADA with soluble EGF at a specific day, p < 0.05, n > 3.
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Fig. 3.
Inclusion of adhesion ligands and tethered growth factor instruct hepatocyte to secrete and
accumulate matrix after 3 days in culture on self-assembling peptide gels. Representative
images of fibronectin and actin (inset) on RADA, RADA + RGD2, RADA + RGD2 + HB
peptide gels with soluble EGF or tEGF 3 days after initial seeding at 100,000 cells/cm2 (Scale
bar = 400 mm, 5× objective). Cells were fixed, permeabilized and stained with anti-rat
fibronectin and four random fields were imaged on each peptide gel sample. Arrows indicate
intracellular staining for fibronectin and arrowheads point to extracellular fibrils of fibronectin.
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Fig. 4.
Primary hepatocytes require presence of RGD, HB and tEGF on peptide gels in order to
synthesize DNA. Quantification of DNA synthesis by BrdU incorporation and active cell cycle
marker Ki67. Hepatocytes (seeded at 65,000 cells/cm2) were cultured on RADA, RADA +
RGD2 and RADA + RGD2 + HB peptide gels with soluble EGF or tEGF and adsorbed collagen
I (Col I). DNA synthesis was quantified by immunofluorescence staining as the percentage of
total nuclei incorporating BrdU (48–72 h) or as the percentage of total nuclei staining positive
for Ki67 (at 48 h). We observed no DNA synthesis at any time point on other peptide gel
(RADA, RADA + RGD2, RADA + RGD2 + HB all with soluble EGF and RADA + tEGF,
RADA + RGD2 + tEGF).
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Fig. 5.
Addition of tEGF to peptide gels with varying adhesion ligands leads to sustained ERK
phosphorylation in hepatocytes. ERK phosphorylation (normalized to GAPDH) at A) 48 h, B)
72 h. Hepatocytes were cultured on RADA, RADA + RGD2 and RADA + RGD2 + HB peptide
gels with soluble EGF or tEGF or tEGF (seeded at 100,000 cells/cm2). Lysates were made
after defined time-points and pERK levels were quantified by immunoprecipitation. * indicates
statistically significant difference from RADA with soluble EGF, ‡ indicates statistically
significant difference between soluble and tethered for a particular peptide gel composition,
p < 0.05, n > 2.
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Fig. 6.
Tethered EGF stimulates sustained EGFR phosphorylation and downregulates ErBB2
phosphorylation in hepatocytes on peptide gels. EGFR phosphorylation (normalized to total
EGFR and GAPDH) at A) 48 h, B) 72 h, and ErbB2 phosphorylation (normalized to total ErbB2
and GAPDH) at C) 48 h, D) 72 h. Hepatocytes were cultured on peptide gels with soluble EGF
or tEGF or tEGF (seeded at 100,000 cells/cm2). Lysates were made after defined time-points
and pEGFR levels were quantified by immunoprecipitation. * indicates statistically significant
difference from RADA with soluble EGF, ‡ indicates statistically significant difference
between soluble and tethered for a particular peptide gel composition, p < 0.05, n > 2.
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Fig. 7.
Tethered EGF maintains total EGFR and downregulates ErbB2 receptor levels on peptide gels.
Total EGFR (normalized to GAPDH) at A) 48 h, B) 72 h, and total ErbB2 (normalized to
GAPDH) at C) 48 h, D) 72 h. Hepatocytes were cultured on peptide gels with soluble EGF or
tEGF or tEGF (seeded at 100,000 cells/cm2). Lysates were made after defined time-points and
pEGFR levels were quantified by immunoprecipitation. * indicates statistically significant
difference from RADA with soluble EGF, ‡ indicates statistically significant difference
between soluble and tethered for a particular peptide gel composition, p < 0.05, n > 2.
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Fig. 8.
Maintenance of metabolic function improves with functionalization of peptide gels with
adhesion ligands and growth factor tethering. A) Albumin secretion, B) Urea production.
Conditioned media from hepatocyte cultures on peptide gels and adsorbed collagen I (seeded
at 100,000 cells/cm2) were collected, and urea and albumin were quantified using standard
assay kits. Culture medium was replaced 48 h prior to collection on the indicated days. Samples,
standards and controls were tested in duplicates. ‡ indicates statistically significant difference
from RADA, p < 0.05, n > 3, Except adsorbed collagen I (ads. col I), all peptide gels contained
RADA. * indicates statistically significant difference from adsorbed collagen I, p < 0.05, n >
3.
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Fig. 9.
Self-assembling peptide gels modified with adhesive ligands and tethered growth factors may
provide adequate microenvironment to various cell types. The peptide backbone can be
modified with a variety of adhesive modifications suitable to the integrin repertoire of any cell
type. Further, inclusion of a biotin modification on the peptide backbone allows any
biotinylated growth factor to be tethered to the gel. Given the stiffness of the peptide gels are
physiological for many tissues, these gels can be modified to suit a wide array of cell types
forming a chemically and mechanically controlled microenvironment.
Mehta et al. Page 28
Biomaterials. Author manuscript; available in PMC 2011 June 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Mehta et al. Page 29
Table 1
Self-assembling peptide gel composition and notation
Composition of the self-assembling
peptide gel
Ratio of
components
Notation in this report
RADA + Biotinylated RADA 9:1 RADA
RADA + Biotinylated RADA + RGD2
 functionalized RADA
8:1:1 RADA + RGD2
RADA + Biotinylated RADA + RGD2
 functionalized RADA + Heparin
 binding functionalized RADA
7:1:1:1 RADA + RGD2 + HB
RADA + Biotinylated
 RADA + tethered EGF
9:1 RADA + tEGF
RADA + Biotinylated RADA + RGD2
 functionalized RADA + tethered
 EGF
8:1:1 RADA + RGD2 + tEGF
RADA + Biotinylated RADA + RGD2
 functionalized RADA + Heparin
 binding functionalized RADA
 tethered EGF
7:1:1:1 RADA + RGD2 + HB + tEGF
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